甲基强的松龙脉冲疗法治疗史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症：生物标志物的临床评估与分析 - Suppr

Suppr

超能文献

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.

作者信息

Hirahara Kazuhisa, Kano Yoko, Sato Yohei, Horie Chiho, Okazaki Aki, Ishida Tadashi, Aoyama Yumi, Shiohara Tetsuo

出版信息

J Am Acad Dermatol. 2013 Sep;69(3):496-8. doi: 10.1016/j.jaad.2013.04.007.

DOI:10.1016/j.jaad.2013.04.007

PMID:23957982

Abstract

摘要

相似文献

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.

J Am Acad Dermatol. 2013 Sep;69(3):496-8. doi: 10.1016/j.jaad.2013.04.007.

Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.

J Allergy Clin Immunol. 2013 Mar;131(3):907-9. doi: 10.1016/j.jaci.2012.08.042. Epub 2012 Oct 16.

Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.

Am J Ophthalmol. 2010 Feb;149(2):354; author reply 355. doi: 10.1016/j.ajo.2009.09.017.

Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.

Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169.

Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.

J Am Acad Dermatol. 2013 Aug;69(2):221-5. doi: 10.1016/j.jaad.2013.04.017. Epub 2013 May 11.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus.

Australas J Dermatol. 2012 Nov;53(4):303-6. doi: 10.1111/j.1440-0960.2011.00842.x. Epub 2011 Dec 29.

Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients.

J Am Acad Dermatol. 2022 Jun;86(6):1236-1245. doi: 10.1016/j.jaad.2022.01.039. Epub 2022 Feb 2.

Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone.

Pediatr Int. 2007 Oct;49(5):659-62. doi: 10.1111/j.1442-200X.2007.02439.x.

Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Int J Dermatol. 2011 Dec;50(12):1570-8. doi: 10.1111/j.1365-4632.2011.05007.x.

Etanercept therapy for toxic epidermal necrolysis.

J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.

引用本文的文献

Survival Following Steroid-Based Therapy in a Case of Penicillin-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap.

Cureus. 2025 Jun 5;17(6):e85396. doi: 10.7759/cureus.85396. eCollection 2025 Jun.

Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience.

Turk J Med Sci. 2025 Feb 5;55(2):461-469. doi: 10.55730/1300-0144.5990. eCollection 2025.

Amniotic membrane grafting for acute ocular involvement in Stevens-Johnson syndrome: Review of perioperative considerations, surgical techniques, and outcomes.

Indian J Ophthalmol. 2025 Apr 1;73(4):553-562. doi: 10.4103/IJO.IJO_1238_24. Epub 2025 Mar 27.

Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient.

Front Immunol. 2025 Jan 23;15:1452245. doi: 10.3389/fimmu.2024.1452245. eCollection 2024.

Case Report: Multi-targeted therapy in the treatment of severe toxic epidermal necrolysis.

Front Pediatr. 2024 Nov 22;12:1460579. doi: 10.3389/fped.2024.1460579. eCollection 2024.

Severe cutaneous adverse reactions.

Nat Rev Dis Primers. 2024 Apr 25;10(1):30. doi: 10.1038/s41572-024-00514-0.

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.

J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.

Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report.

Healthcare (Basel). 2023 Aug 3;11(15):2195. doi: 10.3390/healthcare11152195.

A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.

Management of Drug-Induced Epidermal Necrolysis (DEN) in Pediatric Patients: Moving from Drug-Induced Stevens-Johnson Syndrome, Overlap and Toxic Epidermal Necrolysis to a Single Unifying Diagnosis of DEN.

Paediatr Drugs. 2022 Jul;24(4):307-319. doi: 10.1007/s40272-022-00515-0. Epub 2022 Jun 9.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.

作者信息

Hirahara Kazuhisa, Kano Yoko, Sato Yohei, Horie Chiho, Okazaki Aki, Ishida Tadashi, Aoyama Yumi, Shiohara Tetsuo

出版信息

J Am Acad Dermatol. 2013 Sep;69(3):496-8. doi: 10.1016/j.jaad.2013.04.007.

DOI:10.1016/j.jaad.2013.04.007

PMID:23957982

Abstract

摘要

相似文献

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers.

J Am Acad Dermatol. 2013 Sep;69(3):496-8. doi: 10.1016/j.jaad.2013.04.007.

Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis.

J Allergy Clin Immunol. 2013 Mar;131(3):907-9. doi: 10.1016/j.jaci.2012.08.042. Epub 2012 Oct 16.

Systemic and local management at the onset of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.

Am J Ophthalmol. 2010 Feb;149(2):354; author reply 355. doi: 10.1016/j.ajo.2009.09.017.

Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.

Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169.

Intravenous immune globulin therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis complicated by hemolysis leading to pigment nephropathy and hemodialysis.

J Am Acad Dermatol. 2013 Aug;69(2):221-5. doi: 10.1016/j.jaad.2013.04.017. Epub 2013 May 11.

Toxic epidermal necrolysis-like subacute cutaneous lupus erythematosus.

Australas J Dermatol. 2012 Nov;53(4):303-6. doi: 10.1111/j.1440-0960.2011.00842.x. Epub 2011 Dec 29.

Inhibition of tumor necrosis factor improves conventional steroid therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis in a cohort of patients.

J Am Acad Dermatol. 2022 Jun;86(6):1236-1245. doi: 10.1016/j.jaad.2022.01.039. Epub 2022 Feb 2.

Toxic epidermal necrolysis in a child successfully treated with cyclosporin A and methylprednisolone.

Pediatr Int. 2007 Oct;49(5):659-62. doi: 10.1111/j.1442-200X.2007.02439.x.

Hematological abnormalities and the use of granulocyte-colony-stimulating factor in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis.

Int J Dermatol. 2011 Dec;50(12):1570-8. doi: 10.1111/j.1365-4632.2011.05007.x.

Etanercept therapy for toxic epidermal necrolysis.

J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.

引用本文的文献

Survival Following Steroid-Based Therapy in a Case of Penicillin-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Overlap.

Cureus. 2025 Jun 5;17(6):e85396. doi: 10.7759/cureus.85396. eCollection 2025 Jun.

Evaluation of clinical features and treatment modality of pediatric patients with Steven Johnson syndrome/toxic epidermal necrolysis: a single-center experience.

Turk J Med Sci. 2025 Feb 5;55(2):461-469. doi: 10.55730/1300-0144.5990. eCollection 2025.

Amniotic membrane grafting for acute ocular involvement in Stevens-Johnson syndrome: Review of perioperative considerations, surgical techniques, and outcomes.

Indian J Ophthalmol. 2025 Apr 1;73(4):553-562. doi: 10.4103/IJO.IJO_1238_24. Epub 2025 Mar 27.

Case report: Toxic epidermal necrolysis as a unique presentation of acute graft versus host disease in a pediatric patient.

Front Immunol. 2025 Jan 23;15:1452245. doi: 10.3389/fimmu.2024.1452245. eCollection 2024.

Case Report: Multi-targeted therapy in the treatment of severe toxic epidermal necrolysis.

Front Pediatr. 2024 Nov 22;12:1460579. doi: 10.3389/fped.2024.1460579. eCollection 2024.

Severe cutaneous adverse reactions.

Nat Rev Dis Primers. 2024 Apr 25;10(1):30. doi: 10.1038/s41572-024-00514-0.

Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy.

J Inflamm Res. 2024 Apr 17;17:2337-2351. doi: 10.2147/JIR.S454673. eCollection 2024.

Toxic Epidermal Necrolysis, A Serious Side Effect of Tenoxicam Use: A Case Report.

Healthcare (Basel). 2023 Aug 3;11(15):2195. doi: 10.3390/healthcare11152195.

A Review of the Systemic Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.

Biomedicines. 2022 Aug 28;10(9):2105. doi: 10.3390/biomedicines10092105.

Paediatr Drugs. 2022 Jul;24(4):307-319. doi: 10.1007/s40272-022-00515-0. Epub 2022 Jun 9.